The Methodist Hospital Research Institute
Clinical trials sponsored by The Methodist Hospital Research Institute, explained in plain language.
-
Could a diabetes drug and immune therapy slow Alzheimer's? new trial launches
Disease control Recruiting nowThis early-phase trial tests whether combining interleukin-2 (IL-2) with semaglutide (a diabetes drug) can safely reduce harmful inflammation in the brains of people with Alzheimer's disease. The study will enroll 30 adults aged 50–86 with mild-to-moderate Alzheimer's. Participan…
Phase: PHASE1, PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could VR games shield aging brains from Post-Surgery confusion?
Disease control Recruiting nowThis trial investigates whether playing a virtual reality (VR) cognitive stimulation game can help older adults with mild memory problems stay mentally sharp and avoid delirium after major surgery. Participants, aged 65 and older, will use an Oculus Quest 2 headset for 20 minutes…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New cocktail targets rare breast cancer that defies standard treatment
Disease control Recruiting nowThis phase 2 trial is testing a combination of three drugs—alpelisib, L-NMMA, and nab-paclitaxel—in people with a rare, aggressive form of breast cancer called metaplastic breast cancer (MpBC) that has spread or is locally advanced. The study aims to find the best dose and see if…
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Can a tree bark extract help fight lung cancer? new trial begins
Disease control Recruiting nowThis early-stage trial tests the safety of honokiol, a dietary supplement from magnolia bark, in 15 people with early lung cancer. Participants take honokiol for two weeks before their scheduled surgery. The goal is to find the highest safe dose and check for side effects.
Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Olive extract joins chemo in fight against advanced colon cancer
Disease control Recruiting nowThis early-phase trial tests whether adding hydroxytyrosol, a natural compound found in olives, to standard chemotherapy can safely help people with advanced or metastatic colorectal cancer. About 33 adults who are eligible for first-line treatment will take a daily capsule of hy…
Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could your own belly fat help heal a torn ACL? new stem cell study launches
Disease control Recruiting nowThis early study tests whether a single injection of a patient's own stem cells, taken from the fat pad inside the knee during ACL surgery, can safely improve healing and knee function. Fifteen adults having ACL reconstruction will receive the injection and be followed for side e…
Phase: PHASE1 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could a common virus help brain tumors grow? new trial tests Anti-Viral drug in breast cancer patients
Disease control Recruiting nowThis phase II trial is testing whether an anti-viral drug called valganciclovir (Valcyte) can help treat breast cancer that has spread to the brain. The study includes 28 adults with progressive brain metastases who also have evidence of a common virus called CMV. Participants ta…
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New hope for advanced colon cancer: drug combo trial launches
Disease control Recruiting nowThis Phase II trial is testing a combination of the targeted drug fruquintinib with standard chemotherapy as a first treatment for people with advanced colorectal cancer that cannot be removed by surgery or has spread. Fifty participants will receive the drugs in 28-day cycles, w…
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can vitamin a make a failed myeloma drug effective again?
Disease control Recruiting nowThis study tests whether adding a vitamin A derivative (ATRA) to a standard drug combination (carfilzomib and dexamethasone) can overcome resistance in multiple myeloma patients whose cancer no longer responds to carfilzomib. About 42 adults with relapsed/refractory myeloma will …
Phase: PHASE1, PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Brain cancer gene therapy trial aims to boost survival
Disease control Recruiting nowThis study tests a gene therapy called HSV-tk, given with valacyclovir, alongside standard radiation and chemotherapy for newly diagnosed glioblastoma or anaplastic astrocytoma. The goal is to see if this combination improves overall survival. About 62 participants will be follow…
Phase: PHASE1, PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could an Immune-Suppressing drug treat some forms of schizophrenia?
Disease control Recruiting nowThis study tests whether ocrelizumab, a drug that suppresses certain immune cells, can reduce psychosis symptoms in people whose schizophrenia or bipolar disorder may be caused by auto-antibodies attacking brain receptors. Forty participants aged 18–35 will receive either ocreliz…
Phase: PHASE1, PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Alcohol injection plus standard procedure may calm deadly heart rhythm
Disease control Recruiting nowThis study tests whether adding a vein-injected alcohol treatment to the usual heart ablation procedure can better control dangerous heart rhythms in people with prior heart attacks. About 156 adults with an implanted defibrillator and recent episodes of rapid heartbeat will be r…
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Pre-surgery boot camp may boost recovery for frail cancer patients
Disease control Recruiting nowThis study tests a comprehensive fitness and nutrition program (prehabilitation) given before major cancer surgery. It includes 148 patients with pancreatic, ovarian, kidney, or bladder cancer who are frail or pre-frail. Some patients get the program alone, others get it with che…
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New combo therapy aims to boost prostate cancer fight before surgery
Disease control Recruiting nowThis study tests whether giving a high dose of internal radiation (brachytherapy) before robotic prostate surgery can safely improve outcomes for men with high-risk prostate cancer. About 29 participants will receive the radiation, then surgery, and possibly short-term hormone th…
Phase: PHASE1, PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for breast cancer patients when first treatment fails
Disease control Recruiting nowThis study tests a combination of two drugs, fulvestrant and abemaciclib, for people with a certain type of advanced breast cancer (ER-positive, HER2-negative) that has stopped responding to a first-line treatment called a CDK4/6 inhibitor. The goal is to see if taking a break fr…
Phase: PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a steroid blast calm kidney stent pain?
Symptom relief Recruiting nowThis study tests whether a high dose of the steroid dexamethasone (20 mg) can reduce urinary symptoms and pain after kidney stone surgery when a temporary stent is placed. About 70 adults will receive either the high dose or a standard dose (4 mg) during surgery and report their …
Phase: PHASE1, PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Could CBD be the next painkiller for shoulder surgery patients?
Symptom relief Recruiting nowThis study tests whether Epidiolex (a CBD medicine) can help control pain after shoulder surgery when added to standard painkillers. About 80 adults having rotator cuff repair will take either CBD or a placebo for two weeks after surgery. They will track their pain and medication…
Phase: PHASE1, PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Spinal implant aims to restore arm movement after paralysis
Symptom relief Recruiting nowThis study tests whether a device that sends mild electrical pulses to the spinal cord can help people with a cervical (neck) spinal cord injury regain arm and hand function. The device, called the CoverEdgeX 32 Surgical Lead, is already approved for pain but is investigational f…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Bone injection may cut opioid use after ACL surgery
Symptom relief Recruiting nowThis study tests whether injecting morphine directly into the bone during ACL reconstruction can lower pain and reduce the need for opioid painkillers afterward. About 84 adults aged 18-40 having ACL surgery with a specific type of graft will be randomly assigned to get either th…
Phase: PHASE4 • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Bone stimulator may speed up Athletes' return to sport after spine injury
Symptom relief Recruiting nowThis study tests whether adding a bone stimulator to standard care helps athletes aged 16–40 with a spine stress fracture (spondylolysis) heal faster, reduce pain, and return to sport sooner. About 48 participants will use the device alongside physical therapy. The goal is to see…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Brain zaps aim to calm overactive bladders in MS patients
Symptom relief Recruiting nowThis study tests a non-invasive brain stimulation technique called rTMS to improve bladder symptoms in women with multiple sclerosis. Participants receive either real or sham treatment over 10 sessions. The goal is to see if targeting specific brain areas can reduce urinary urgen…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can remote arm exercises ease dementia caregiver burden?
Symptom relief Recruiting nowThis study tests whether home-based telerehabilitation therapy—hand and arm exercises prescribed by an occupational therapist and done remotely—is feasible and helpful for stroke survivors with vascular dementia. The main goal is to see if it lessens the burden on family caregive…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Tailored brain zaps show promise for stroke recovery
Symptom relief Recruiting nowThis study tests whether a personalized form of brain stimulation (tDCS) can help people who had a stroke more than 3 months ago regain arm movement. Researchers will use brain scans to tailor the stimulation to each person and measure changes in brain connectivity and motor func…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Could a simple nerve zap boost stroke rehab?
Symptom relief Recruiting nowThis study tests whether a non-invasive nerve stimulation (taVNS) combined with occupational therapy can improve arm movement in people who had a stroke at least 6 months ago. 60 participants will receive the stimulation during therapy sessions. The goal is to see if this approac…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Can a chaplain or therapist extend life in advanced cancer? large trial aims to find out
Symptom relief Recruiting nowThis phase 3 trial is testing whether adding chaplain-provided spiritual care or psychotherapy/meditation to standard palliative care can improve survival and quality of life in people with advanced, non-curable cancer. About 854 participants with a life expectancy of one year or…
Phase: PHASE3 • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Family voice recordings tested as delirium therapy in ICU
Symptom relief Recruiting nowThis pilot study tests whether playing recorded messages from family and friends—called VoiceLove therapy—can help manage delirium in surgical ICU patients. Fifteen participants will listen to reorientation and calming messages for 25 minutes, twice a day, for three days. The mai…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Brain camera could spot which cells are causing Alzheimer's inflammation
Knowledge-focused Recruiting nowThis study uses special PET scans to look at two types of brain cells involved in inflammation in Alzheimer's disease. Researchers will give participants two different tracers to see microglia and astrocytes separately. The goal is to develop a method that can tell these cells ap…
Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Spinal stimulation showdown: which technique helps paralyzed patients stand?
Knowledge-focused Recruiting nowThis study compares two types of spinal stimulation—transcutaneous (through the skin) and epidural (implanted via surgery)—to see how they help people with spinal cord injury generate leg force and stand with support. Sixty adults aged 22-75 who cannot stand independently will pa…
Phase: NA • Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
MRI scans could make leg artery procedures safer
Knowledge-focused Recruiting nowThis study uses MRI scans to look at plaque buildup in leg arteries of people with peripheral arterial disease. Researchers want to see which plaques are hard to cross with a guidewire and which devices cause the least damage to the vessel wall. The study includes patients underg…
Sponsor: The Methodist Hospital Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC